Manuel Ramos-Vázquez

Primary Results of ROSE/TRIO-12, a Randomized Placebo-Controlled Phase III Trial Evaluating the Addition of Ramucirumab to First-Line Docetaxel Chemotherapy in Metastatic Breast Cancer

John R. Mackey, Manuel Ramos-Vázquez, Oleg Lipatov et al. · Journal of Clinical Oncology · 2014 · 135 citations · Full text

MicroRNA Expression Profiling of Peripheral Blood Samples Predicts Resistance to First-line Sunitinib in Advanced Renal Cell Carcinoma Patients

Angelo Gámez‐Pozo, Luis Antón-Aparicio, Cristina Bayona et al. · Neoplasia · 2012 · 71 citations · Full text

Maintenance treatment with Pegylated liposomal doxorubicin versus observation following induction chemotherapy for metastatic breast cancer: GEICAM 2001-01 study

Emilio Alba, Manuel Ruíz‐Borrego, Mireia Margelí Vila et al. · Breast Cancer Research and Treatment · 2010 · 69 citations

Pegylated Liposomal Doxorubicin, Metastatic Breast Cancer, Oncology +8

Overeating, caloric restriction and breast cancer risk by pathologic subtype: the EPIGEICAM study

Virginia Lope, Miguel Martín, Adela Castelló et al. · Scientific Reports · 2019 · 32 citations · Full text

A Phase II Study of Weekly Vinorelbine and Trastuzumab in Patients with HER2-Positive Metastatic Breast Cancer

Juan Bayo-Calero, José Mayordomo, Pedro Sánchez‐Rovira et al. · Clinical Breast Cancer · 2008 · 23 citations

Breast Oncology, Medicine, Pharmacology +9